Navegando por CNPq "CNPQ::CIENCIAS BIOLOGICAS::IMUNOLOGIA::IMUNOGENETICA"

Agora exibindo 1 - 4 de 4

Acesso aberto (Open Access)
Avaliação dos fatores de risco associados à transmissão do HTLV-1 e do HTLV-2, em doadores de sangue, na cidade de Belém do Pará
(Universidade Federal do Pará, 2006-04-10) LOPES, Bruna Pedroso Tamegão; LEMOS, José Alexandre Rodrigues de; http://lattes.cnpq.br/0820294977759092
In order to define the epidemiological profile of the Human T-cell Lymphotropic Virus (HTLV-1 and HTLV-2) among inapt blood donors population, at the HEMOPA Foundation, in Belém, state of Pará, we analyzed 113 epidemiological forms, related with risk factors associated with these retrovirus transmission, among carriers and noncarriers of HTLV. We observed that 76% (n=50) of the inapt blood donors were infected by HTLV-1 and 24% (n=16) by HTLV-2; 62% (n=70) of the carriers were male and 38% (n=43) were female, with a tendency of infection in this gender (p=0,007). The risk factors which exhibited significant results were: have received blood transfusion (p=0,0003), more specifically to HTLV-2 (p=0,02); have been breastfeeding from non-mother (p=0,006), more specifically to HTLV-1 (p=0,04); have been submitted to surgery (p=0,01), discriminately to HTLV-1 (p=0,03) and HTLV-2 (p=0,04); share blades/shavers (p=0,02), more specifically to HTLV-1 (p=0,02); do not use condoms during sexual intercourse (p=0,0003), discriminately to HTLV-1 (p=0,001) and HTLV-2 (p=0,002). Despite of the diverse stages existing in the process of selection of blood donors, which the main objective is to eliminate potentials candidates carrying transmissible blood diseases, in special of chronic and asymptomatic course, exist bias that disable an exempt process of fails.
Acesso aberto (Open Access)
Epidemiologia molecular do Vírus linfotrópico de células T humanas - HTLV 1/2 no Estado do Amapá-Brasil
(Universidade Federal do Pará, 2006) SILVA, Ivanete do Socorro Pinheiro da; ISHAK, Marluísa de Oliveira Guimarães; http://lattes.cnpq.br/2847150361567807
The geographical distribution of the infection by human T-cell lymphotropic virus 1/2 – HTLV 1 / 2 is extensive, nevertheless, there are areas that are more endemic and have more particularities depending on the HTLV type. The HTLV 1 shows a bigger occurrence in south west of Japan, Caribbean, Central America, in different regions of South America and in parts of Central, as well as in western Africa, while HTLV-2, seems to assault distinct groups of people, such as Indians native people from North, Central and South America, Pigmies from Central Africa, Mongols in Asia as well as in infecting drug users. The present work had as objective describing HTLV molecular epidemiology, in three different populations the State of Amapá, they are: HIV/IDS positive patients, Afro-descenig population and individuals assisted of Public Health Center Laboratory of Amapá – LACEN-AP, directed for diagnosis of HTLV. The samples were tested for the presence of virus using serological (ELISA and Western blot) and molecular assays (gene amplification and restriction fragment length polymorphism from pX and env for the analysis of polimorfismo o restriction fragments for endonuclease action. The obtained results in different populations are In the population of HIV infected people, all the samples were negative; in the Afro-desceding population, only one sample was positive confirmed by serological test (ELISA), but negative according to western blot test and submitted to the molecular analysis, there wast not amplification. However, among samples of individuals directed for diagnosis of HTLV, 06 (six) were positive, 5(five) out of 6/them were confirmed by western blot test. The molecular result demonstrated the presence of HTLV-1.
Acesso aberto (Open Access)
Perfil de MicroRNAs hepáticos pode regular apoptose, lesões vasculares e inflamação na dengue hemorrágica
(Universidade Federal do Pará, 2016-06-30) OLIVEIRA, Layanna Freitas de; BURBANO, Rommel Mario Rodriguéz; http://lattes.cnpq.br/4362051219348099
Dengue is the most prevalent arbovirosis in the world caused by Dengue virus (DENV) and is present in all continents, for more than three decades has been a constant public health concern and often fatal by dengue hemorrhagic fever (DHF). The pathogenesis of dengue is closely related to the host immune response, reaching exacerbated inflammation and transient autoimmunity. All tissues are affected, which liver is one of the most important in severe conditions, due its intense viral replication and its significant role in metabolism. The study of microRNAs (miRNA) as regulatory elements of metabolism and immune response during infection is crucial to understanding the regulatory mechanisms of gene expression on DENV infection, and can help in diagnostic development of anti-viral therapies. We sequenced the miRNoma in MySeq platform (Illumina) to identify the miRNAs profile expressed in FFPE liver tissue, ten DHF fatal cases were compared to five control cases. Eight miRNAs exhibited differential expression in DHF liver, miR-126-5p, a regulatory molecule of endothelial cells, and miR-133a-3p are upregulated in dengue and miR-122-5p, a liver-specific miRNA, miR- 146a-5p, interferon regulator, miR-10b-5p, miR-204-5p, miR-148a-5p and miR-423-5p were downregulated. Functional analysis of KEGG pathways and GO terms with predicted target genes of overexpressed miRNAs found regulatory pathways of apoptosis and immune response, involving MAPK gene, RAS, CDK and FAS; immune response pathways showed NF- kB, CC and CX families, IL and TLR. The same analysis with target genes of downregulated miRNAs also identified in most pathways of apoptosis and biosynthetic pathways of metabolism. In our knowledge, this is the first description of the liver miRNA profile in DHF, the results together show a feasible relationship of miR-126-5p, miR-122-5p and miR-146a-5p with liver pathogenesis of DHF, through endothelial repair and vascular permeability regulation, control of homeostasis and liver expression regulation of inflammatory cytokines.
Acesso aberto (Open Access)
Polimorfismo do gene da interleucina IL-1B e sua associação com o risco ao desenvolvimento do câncer gástrico em uma população do norte do Brasil
(Universidade Federal do Pará, 2016-12-22) CASTRO, Yaisa Gomes de; SANTOS, Ândrea Kely Campos Ribeiro dos; http://lattes.cnpq.br/3899534338451625
Cancer is understood as a set of diseases with similar characteristics, but with great heterogeneity that occurs in a random manner and covers both tumor and inflammatory and immune cells. Gastric tumors, in Brazil and notably in the State of Pará, have a high incidence. In general, gastric cancer has a multifactorial etiology. Communication and cellular signaling that regulate the immune system are facilitated by interleukins that represent small, specific proteins, have diverse functions, they regulate transcription factors, role genes, inflammation, differentiation, proliferation, and secretion of antibodies. Single polymorphism nucleotide, in specific IL-1B proinflammatory interleukin gene, is associated with the immune response to H. pylori infection. Thefore variations within the IL-1 family genes were associated with susceptibility to the development of gastric cancer. In this case-control study, we investigated whether the polymorphisms IL-1BF1 (rs16944) and IL-1BE1 (rs1143627) are associated with the risk of developing gastric cancer in a population from the north of Brazil; Compared to their respective genotypes, defined haplotypes and these related to ancestry and their rates. SNPs were genotyped by VIC / FAM (Real Time PCR, Fluorescent, Life Technologies, CA, USA) labeled probes. The biostatistical analyzes showed that for the demographic variables, there were significant differences between the groups in European and African ancestry. The distribution of the genotypic, allelic and haplotype frequencies of the IL-1B gene was not statistically significant between the groups. More comprehensive studies and analyzes are needed to help understand better why these polymorphisms in this population do not appear to be associated with the development of the disease in question.